공지사항Home > 뉴스브리핑센터 > 공지사항
|[KIOM] 논문 모집 공고 Special Issue: “Integrative Medicine for COVID-19: Researches and Evidence”|
한국한의학연구원(KIOM)에서 발행하는 SCI급 저널인 INTEGRATIVE MEDICINE RESEARCH에서 현재 “Integrative Medicine for COVID-19: Researches and Evidence" 주제로 특별호에 실릴 원고를 모집 중에 있습니다. 제출 마감은 2020년 6월 14일까지입니다. 코로나19 관련 통합의학에 관심 있으신 분들의 많은 투고 부탁드립니다.
문의: IMR 사무국 042-828-9392 / firstname.lastname@example.org
Call for Papers on the Special Issue: “Integrative Medicine for COVID-19: Researches and Evidence”
•Junhua Zhang (✉email@example.com) Tianjin University of Traditional Chinese Medicine, China
•Myeong Soo Lee (✉firstname.lastname@example.org) Korea Institute of Oriental Medicine, Korea
•Myungsoo Joo (✉email@example.com) Pusan National University, Korea
•Jun-Yong Choi (✉firstname.lastname@example.org) Pusan National University, Korea
Aims and scope of the special issue
Coronavirus disease 2019 (COVID-19) is spreading worldwide. China's experience, for controlling of the current epidemic and treating patients, is of significant valuable for other countries to fight with COVID-19. In particular, traditional medicine therapies, such as prescription decoction, Chinese patent medicine, acupoint stimulation and Taiji, alone or adding to conventional drug therapies have been widely used and played a positive role in the mild, moderate and severe cases. In order to evaluate the efficacy and safety of traditional medicine therapies, there are hundreds of clinical study protocols registered in different registries. After the trials are completed, more evidence will be achieved, which will benefit the generalization and rational application of traditional medicine therapies. With the purpose of sharing knowledge and experience of traditional medicines for the treatment of COVID-19, the special issue of Integrative Medicine Research will provide evidence for the prevention and treatment of COVID-19.
The journal’s uses online submission system: www.editorialmanager.com/IMRES/
During submission, please select the article type “SI: COVID-19”
Time of submission: until 14 June 2020*
* As IMR uses article-based publishing workflow and evaluates submissions as soon as they are received, submission for special issue may close in advance if the number of accepted/online published special issue articles exceeds certain number.
For submission instructions, please refer to the journal’s Guide for Authors:
Types of articles
Randomized clinical trial
Case series/Case report
Experimental study (in vivo and in vitro)
IMR Editorial Office: ✉email@example.com